Market research
ASIT.BR ASIT Biotech S.A
BR EUR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- 3.8
- Dividend yield
- 0.0%
- Beta
- 1.33
Community
Investor discussion
1 comment
Sign in to join the ASIT.BR discussion.
5 years, 6 months ago
ASIT Biotech S.A is currently in a long term uptrend where the price is trading 6.4% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Based on the above factors, ASIT Biotech S.A gets an overall score of 2/5.